- Home
- / HealthEquity
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CreditSafe score
?
Score changed on Jan 30, 2023
Premium Content
Learn moreFinancial statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|
| Revenue | 532.0M | 733.6M | 756.6M |
| Cost of goods sold | 206.1M | 318.2M | 332.9M |
| Gross profit | 325.9M | 415.3M | 423.7M |
| Gross profit margin, % | 61.3% | 56.6% | 56.0% |
| General and administrative expense | 60.6M | 84.5M | 84.4M |
| Operating expense total | 248.9M | 381.3M | 447.9M |
| Depreciation and amortization | 20.6M | 39.8M | 54.4M |
| EBIT | 77.0M | 34.0M | (24.2M) |
| EBIT margin, % | 14.5% | 4.6% | -3.2% |
| Interest expense | 24.8M | 34.9M | 36.6M |
| Pre tax profit | 43.2M | 4.1M | (66.7M) |
| Income tax expense | 3.5M | (4.7M) | (22.5M) |
| Net Income | 39.7M | 8.8M | (44.3M) |
| EPS | 0.6 | 0.1 | (0.5) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |